Copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Anesthesiol. Sep 27, 2020; 9(1): 1-2
Published online Sep 27, 2020. doi: 10.5313/wja.v9.i1.1
Published online Sep 27, 2020. doi: 10.5313/wja.v9.i1.1
Low dose corticosteroids in COVID-19 with refractory shock: We are not sure?
Amr Salah Omar, Department of Cardiothoracic Surgery/Cardiac Anaesthesia and ICU, Heart Hospital, Hamad Medical Corporation, Doha 3050, Qatar
Amr Salah Omar, Department of Critical Care Medicine, Beni Suef University, Beni Suef 71515, Egypt
Amr Salah Omar, Department of Medicine, Weill Cornell Medical College in Qatar, Doha 3050, Qatar
Author contributions: Omar AS solely contributed to this manuscript.
Conflict-of-interest statement: The author has no conflicts of interest to declare.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Amr Salah Omar, MBChB, MD, MSc, PhD, Professor, Department of Cardiothoracic Surgery/Cardiac Anaesthesia and ICU, Heart Hospital, Hamad Medical Corporation, Doha 3050, Qatar. a_s_omar@yahoo.com
Received: May 27, 2020
Peer-review started: May 27, 2020
First decision: July 21, 2020
Revised: July 22, 2020
Accepted: August 15, 2020
Article in press: August 15, 2020
Published online: September 27, 2020
Peer-review started: May 27, 2020
First decision: July 21, 2020
Revised: July 22, 2020
Accepted: August 15, 2020
Article in press: August 15, 2020
Published online: September 27, 2020
Abstract
Low dose corticosteroids to adult patients with coronavirus disease 2019 (COVID-19) and refractory shock was given some evidence, the evidence was of low quality given particularly for shock-reversal. Evidence. However bacterial sepsis may not provide a similar evidence like in a viral related one. We think that suggesting steroids for COVID-19 may not be adequate in the current time and future data analysis should be directed to find possible evidence in a matched population
Keywords: Corticosteroids, Sepsis, Shock, COVID-19, Refractory, Outcome
Core Tip: We think that suggesting steroids for coronavirus disease 2019 may not be adequate in the current time and future data analysis should be directed to find possible evidence in a matched population.